Related Experiment Video
Updated: May 15, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Acitretin treatment for lipoid proteinosis
Ozgür Gündüz1, Neriman Sahiner, Pınar Atasoy
1Department of Dermatology and Venerology, Suleyman Demirel Teaching Hospital, University of Kırıkkale, Fabrikalar Mahallesi, Saglık Sokak, Kırıkkale 71100, Turkey.
Abstract:
Lipoid proteinosis (LP) is a rare, autosomal-recessive disease characterized by the hoarseness and widespread cutaneous scarring, more prominent on sun-exposed areas. Yellow-white plaques can be seen on oral mucosa and on the skin among depressed scars. Histological evaluation of the affected sites shows accumulation of hyaline-like material in dermis and disruption of basement membrane. Although LP is compatible with normal life expectancy, involvement of upper respiratory tract may endanger patient's life, especially in the case of a respiratory tract infection. Involvement of central nervous system has also been reported, but its clinical importance is obscure. Due to the rarity of LP, a definite therapeutical approach is not established. In this paper we describe a 21-year-old LP patient who was treated with acitretin for six months. Although the outcome with cutaneous lesions was not satisfactory, her hoarseness was significantly improved.
Related Concept Videos
Acne Infection
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
